Cargando…
A preclinical PET dual-tracer imaging protocol for ER and HER2 phenotyping in breast cancer xenografts
BACKGROUND: Nuclear medicine is on the constant search of precision radiopharmaceutical approaches to improve patient management. Although discordant expression of the estrogen receptor (ER) and the human epidermal growth factor receptor 2 (HER2) in breast cancer is a known dilemma for appropriate p...
Autores principales: | Paquette, Michel, Phoenix, Serge, Lawson, Christine, Guérin, Brigitte, Lecomte, Roger, Tai, Lee-Hwa, Turcotte, Éric E., Leyton, Jeffrey V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7334319/ https://www.ncbi.nlm.nih.gov/pubmed/32592121 http://dx.doi.org/10.1186/s13550-020-00656-8 |
Ejemplares similares
-
Protocols for Dual Tracer PET/SPECT Preclinical Imaging
por: Blower, Julia E., et al.
Publicado: (2020) -
A Dual Tracer (18)F-FCH/(18)F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model
por: Fu, Yilong, et al.
Publicado: (2016) -
Quantitative hormone therapy follow-up in an ER+/ERαKD mouse tumor model using FDG and [(11)C]-methionine PET imaging
por: Paquette, Michel, et al.
Publicado: (2012) -
Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [(68)Ga]Ga-FAPI-RGD
por: Zang, Jie, et al.
Publicado: (2022) -
In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model
por: van der Wildt, Berend, et al.
Publicado: (2018)